Two top progressive Democrats asked antitrust regulators to examine UnitedHealth Group’s planned $3.3 billion purchase of home-health provider Amedisys Inc. and challenge deals that bring medical providers under the same ownership as health insurers. The Department of Justice opened an in-depth probe into the deal in August, and the letter from Senator Elizabeth Warren and Representative Pramila Jayapal renews attention on the investigation. The lawmakers stopped short of telling regulators to block the deal, but Warren and Jayapal, who are leading voices on the left wing of the Democratic party, continue to pressure a Biden administration that has struggled to sway courts to block deals, Bloomberg reports. Read more.
Related Posts
Rural Areas Could Be a Prime Target for Behavioral Health Providers, Investors
As behavioral health organizations and investors look for different ways to grow, rural communities present opportunities to address higher-than-average unmet needs for mental health services and capitalize on challenging workforce trends.
February 21, 2023
Providence Targeted by Oregon Consumer Protection Probe
The consumer probe follows a New York Times report last month that described aggressive billing practices targeting patients who should have received free or discounted care by the Renton, Washington-based hospital chain.
October 17, 2022
Health Care/Life Sciences Poised as Alternative Investors’ Best Sector for Q4 Investments as Tech Outlook Falters
Despite a tepid macroeconomic outlook, survey respondents still see opportunity in the fourth quarter.
October 26, 2022
General Catalyst Exec Discusses AI in Healthcare
Holly Maloney, managing director of General Catalyst, discussed responsible AI use in healthcare and what the company looks for in a startup when considering an investment.
April 24, 2023